Top Markets
#1 Wibx Wibx +8.04%
#2 Wrapped Flare Wrapped Flare +4.46%
#3 Decred Decred +4.31%
#4 Humanity Humanity +4.26%
#5 Across Protocol Across Protocol +3.82%
#6 Pearl Pearl +3.51%
#7 aelf aelf +3.44%
#8 Audiera Audiera +2.66%
#9 MarsCoin MarsCoin +2.24%
#10 TRIA TRIA +2.06%
Coin of the day
Wibx Wibx
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.

Inhibitor Therapeutics, Inc.

INTI
Classifica tra le azioni #30838
Inhibitor Therapeutics, Inc., established in 1992 and based in Tampa, Florida,... Inhibitor Therapeutics, Inc., established in 1992 and based in Tampa, Florida, is a pharmaceutical development enterprise. The company is dedicated to inventing and commercializing medical treatments for patients in the United States who suffer from various cancerous and non-cancerous cell proliferation conditions. A primary focus of their work involves advancing SUBA-Itraconazole, an oral variant of the drug itraconazole, for therapeutic applications in prostate and lung cancers. Furthermore, Inhibitor Therapeutics, Inc. has successfully completed a positive Phase 2b clinical trial for SUBA-Itraconazole in the management of basal cell carcinoma nevus syndrome. The organization was previously known as HedgePath Pharmaceuticals, Inc. until its name was officially changed in August 2019.
Prezzo delle azioni
$0.089
Ultima sincronizzazione: 2026-08-17
Capitalizzazione di mercato
$15.36M
Variazione (1 giorno)
50.59%
Variazione (1 anno)
72.65%
Paese
US
Scambia Inhibitor Therapeutics, Inc. (INTI)

Categoria

Healthcare
Il prezzo INTI con la capitalizzazione del mercato della B
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.
INTI
$0.089
Capitalizzazione di mercato di Inhibitor Therapeutics, Inc.(INTI)
Capitalizzazione di mercato: $15.36M
A partire dal August 2026, Inhibitor Therapeutics, Inc. ha una capitalizzazione di mercato pari a $15.36M. Questo rende Inhibitor Therapeutics, Inc. la 30838th azienda più preziosa al mondo per capitalizzazione di mercato secondo i nostri dati. La capitalizzazione di mercato è il valore totale delle azioni in circolazione di una società quotata e viene comunemente utilizzata per misurarne il valore.
Storia della capitalizzazione di mercato di Inhibitor Therapeutics, Inc. dal 2003 al 2026
INTI in paragone con la classifica dei più popolari stocks
Il prezzo per INTI Attivo B Capitalizzazione del mercato a B Risultati
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.
$30,749.66 $15.36M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.307T +34,550,085.07%
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.
$26,369.80 $15.36M
Apple Inc. Apple Inc.
AAPL
$4.551T +29,628,891.27%
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.
$24,072.99 $15.36M
Alphabet Inc. Alphabet Inc.
GOOG
$4.154T +27,048,208.47%
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.
$20,794.30 $15.36M
Microsoft Corporation Microsoft Corporation
MSFT
$3.589T +23,364,277.97%
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.
$16,206.69 $15.36M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.797T +18,209,663.87%